Back
Speaker illustration

Mr Mauro Trincado Ave

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

Presentations Articles

H558R: a common polymorphism may modify the efficacy and toxicity of flecainide in maintaining sinus rhythm; a cohort study.

Event: ESC Congress 2024

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: Rhythm control in atrial fibrillation: prognostic and therapeutic implications

Access
Like
Thumbnail

Do CYP2D6 polymorphisms affect the efficacy and toxicity of flecainide? A cohort study.

Event: ESC Congress 2024

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: Rhythm control in atrial fibrillation: prognostic and therapeutic implications

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources